Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: June 2008
-
By Christopher P. Singer — On Monday, FierceBiotech published its annual "Fierce 15" list of what it considers to be among the most promising of the up-and-coming companies in the biotechnology industry. FierceBiotech, a daily biotech industry news provider, has been publishing the Fierce 15 since 2003. The companies below (listed alphabetically) were…
-
By Christopher P. Singer — In April, the U.S. Patent and Trademark Office announced that it had updated the training materials to be used by examiners in the examination of patent applications for compliance with the written description requirement of 35 U.S.C. § 112, first paragraph. The revised training materials supersede and replace…
-
By Kwame Mensah — Last month, Chemokine Therapeutics Corp. announced that it has been granted U.S. Patent Nos. 7,354,899, entitled "Methods of treating Autoimmune Diseases Comprising Administering CXCR4 Antagonists" and 7,368,425, entitled "Cyclic Peptides for Modulating Growth of Neo-Vessels and Their Use in Therapeutic Angiogenesis." With the issuance of the ‘899 and ‘425…
-
By Donald Zuhn — Last Thursday, a diverse panel comprising both in-house and outside counsel and both corporate and venture capital interests participated in a breakout session at the BIO International Convention to discuss IP challenges and strategies for biotech and pharma companies as a result of pending USPTO rules changes and possible…
-
By Donald Zuhn — Last Wednesday, a panel of representatives from the Japanese Patent Office (JPO), European Patent Office (EPO), Chinese Patent Office (SIPO), and U.S. Patent Office (USPTO) participated in a breakout session at the BIO International Convention to update attendees on recent developments regarding the patent law, rules, and procedures in…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Jassen, L.P. et al. v. KV Pharmaceutical Co.3:08-cv-03012; filed June 17, 2008 in the District Court of New Jersey Infringement of U.S.…
-
June 23, 2008 – Multilateral Patents (Law Seminars International) – San Francisco, CA July 1, 2008 – Prior Art & Obviousness 2008: The PTO and CAFC Perspective on Patent Law Sections 102 & 103 (Practising Law Institute) – New York, NY July 9-11, 2008 – Fundamentals of Patent Prosecution 2008: A Boot Camp for Claim…
-
American Conference Institute (ACI) will be holding its 9th Annual Maximizing Pharmaceutical Patent Lifecycles conference on October 15-16, 2008 in New York. At the conference, ACI's faculty will offer presentations on the following topics: • Clarifying the evolving meaning of 'patent life cycle' for the pharmaceutical business;• Constructing, adjusting, and executing a pharmaceutical patent life…
-
By Kevin E. Noonan — Steven Burrill, President and CEO of Burrill & Co., unveiled his company’s "State of the Biotechnology Industry" report on Wednesday at BIO 2008 in San Diego. Mr. Burrill (below) described developments globally that he anticipates will occur by 2020 and how those changes will impact the industry. Mr.…
-
By Christopher P. Singer — As we reported on Tuesday, the Patent Cooperation Treaty (PCT) has published an amended fee schedule for application filings that is due to take effect on July 1, 2008. In a Federal Register Notice that was published on Wednesday, June 18, 2008, the U.S. Patent and Trademark Office…
Patent Docs 